Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice

The Centers for Disease Control and Prevention (CDC) is expecting a 3 to 10 month nationwide shortage of APLISOL®, a product of Par Pharmaceuticals. APLISOL® is one of two purified-protein derivative (PPD) tuberculin antigens that are licensed by the United States Food and Drug Administration (FDA) for use in performing tuberculin skin tests. The manufacturer notified CDC that they anticipate a supply interruption of APLISOL® 5 mL (50 tests) beginning in June 2019, followed by a supply interruption of APLISOL® 1 mL (10 tests) in November 2019. The expected shortage of APLISOL® 1 mL (10 tests) could occur before November 2019, if demand increases before then. The 3-10 month timeframe for the nationwide shortage is the manufacturer’s current estimate and is subject to change. Read More...

The Source Newsletter

The Network has now been transfered to the National Association for Public Safety Infection Control Officers - NAPSICO.

NAPSICO offers The Source newsletter to members of the Infection Control Network. This bimonthly newsletter comes in two editions to help keep Network members abreast of current infection control issues. One newsletter is tailored for the medical and dental community and the other for law enforcement, fire/rescue, and ambulance service personnel.

For more information contact us at www.NAPSICO.org.

2018 - OSHA/ Infection Control Annual Update Training

Bewildered by what to include in this years infection control training. Wish someone had just written a presentation for you. Look No Further! We have you covered! Follow our scripted presentation. Zika, Ebola and MERS included. 

 Order Here Today

Are Antibacterial Soaps Safe?

Are Antibacterial Soaps Safe? Companies say there's no cause for alarm, but studies suggest they may be dangerous. Now the FDA is preparing to rule. 

Is the quest for clean doing more harm than good?

Read more...